Man Group plc bought a new position in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 697,552 shares of the company’s stock, valued at approximately $11,719,000. Man Group plc owned approximately 0.53% of Surgery Partners as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of SGRY. UBS Group AG boosted its holdings in Surgery Partners by 111.4% in the 4th quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock worth $120,571,000 after buying an additional 4,113,052 shares during the period. Irenic Capital Management LP raised its holdings in Surgery Partners by 740.2% during the 1st quarter. Irenic Capital Management LP now owns 711,000 shares of the company’s stock valued at $8,475,000 after acquiring an additional 626,380 shares during the period. Dimensional Fund Advisors LP raised its holdings in Surgery Partners by 7.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock valued at $63,131,000 after acquiring an additional 389,831 shares during the period. Hsbc Holdings PLC lifted its position in shares of Surgery Partners by 104.2% during the fourth quarter. Hsbc Holdings PLC now owns 1,931,577 shares of the company’s stock worth $30,151,000 after acquiring an additional 985,748 shares in the last quarter. Finally, Clearline Capital LP purchased a new stake in shares of Surgery Partners during the fourth quarter worth $3,088,000.
Insider Transactions at Surgery Partners
In other Surgery Partners news, Director Teresa Deluca bought 10,000 shares of Surgery Partners stock in a transaction that occurred on Tuesday, August 18th. The stock was acquired at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the transaction, the director directly owned 66,843 shares in the company, valued at $959,197.05. This represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 2.00% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Report on Surgery Partners
Surgery Partners Stock Performance
NASDAQ SGRY opened at $13.93 on Friday. The company’s 50 day simple moving average is $15.51 and its two-hundred day simple moving average is $14.39. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.95 and a quick ratio of 1.78. Surgery Partners, Inc. has a 1 year low of $11.41 and a 1 year high of $23.44. The stock has a market capitalization of $1.82 billion, a PE ratio of -19.90, a P/E/G ratio of 4.33 and a beta of 1.91.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.04. The firm had revenue of $848.90 million during the quarter, compared to analyst estimates of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.17 EPS. Analysts predict that Surgery Partners, Inc. will post 0.22 earnings per share for the current fiscal year.
About Surgery Partners
Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.
Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.
Featured Stories
- Five stocks we like better than Surgery Partners
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Free Report).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
